Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial-Reference-Cited by-同舟云学术

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial

Published:2024-01 Issue: Volume:Volume 19 Page:205-216
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Beeh Kai-Michael^ORCID,Scheithe Karl,Schmutzler Heike,Krüger Saskia^ORCID

Publisher

Informa UK Limited

Reference48 articles.

1. European Medicines Agency: EMA/697484/2018 – Elebrato Ellipta. Available from: https://www.ema.europa.eu/en/documents/overview/elebrato-ellipta-epar-medicine-overview_en.pdf. Accessed November 30, 2023.

2. European Medicines Agency: EMA/229136/2019 – Trimbow. Available from: https://www.ema.europa.eu/en/documents/overview/trimbow-epar-medicine-overview_en.pdf. Accessed November 30, 2023.

3. European Medicines Agency: EMA/561272/2020 – Trixeo Aerosphere. Available from: https://www.ema.europa.eu/en/documents/overview/trixeo-aerosphere-epar-medicine-overview_en.pdf. Accessed November 30, 2023.

Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review

5. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to single inhaler triple therapy and digital inhalers in Chronic Obstructive Pulmonary Disease: a literature review and protocol for a randomized controlled trial (TRICOLON study);BMC Pulmonary Medicine;2024-07-04